Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 1/20 | 0.41 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.41 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.41 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.40 |
| ▸ | HTR7 | P34969 | 1/20 | 0.39 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.38 |
| ▸ | DRD2 | P14416 | 1/20 | 0.37 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.37 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.37 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.37 |
| ▸ | HTR2C | P28335 | 1/20 | 0.37 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6001626 | 0.85 | MTNR1B (0.47) | CHRNA7MTNR1BDRD2OPRM1OPRK1 | |
| SCHEMBL7684611 | 0.82 | HTR1A (0.43) | CHRNA7HTR2C | |
| SCHEMBL7677541 | 0.82 | CHRNA7 (0.42) | CHRNA7MTNR1BOPRM1OPRK1 | |
| SCHEMBL7686914 | 0.79 | HTR7 (0.40) | CHRNA7HTR7MTNR1BHTR2C | |
| SCHEMBL7680686 | 0.79 | ALDH1A1 (0.46) | CHRNA7MTNR1BHTR2C | |
| SCHEMBL7680070 | 0.78 | CHRNA7 (0.67) | CHRNA7OPRM1OPRK1OPRL1HTR2C | |
| SCHEMBL7680425 | 0.78 | CHRNA7 (0.67) | CHRNA7OPRM1OPRK1OPRL1HTR2C | |
| SCHEMBL7678292 | 0.78 | CHRNA7 (0.67) | CHRNA7OPRM1OPRK1OPRL1HTR2C | |
| SCHEMBL6001612 | 0.77 | DRD2 (0.49) | DRD2HTR2C | |
| SCHEMBL6002146 | 0.77 | HTR1A (0.45) | HTR2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6417183-B1 | DRUGS RELATES TO 1,4-DIAZACYCLOHEPTANES, TO PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND TO THEIR USE IN METHODS OF THERAPEUTIC TREATMENT OF NERVOUS SYSTEM DISORDERS | ASTRAZENELA UK LIMITED (GB) | 2002-07-09 | — | — | US | disclosed |
| EP-1060169-A1 | 1,4-DIAZACYCLOHEPTANE DERIVATIVES | AstraZeneca AB (SE) | 2000-12-20 | — | — | EP | disclosed |
| WO-1999032461-A1 | 1,4-DIAZACYCLOHEPTANE DERIVATIVES | ASTRAZENECA UK LIMITED (GB) | 1999-07-01 | — | — | WO | disclosed |